Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 151 to 200 of 8183 results

  1. Medical technologies guidance

    Our medical technologies guidance evaluates new, innovative medical devices and diagnostics.

  2. Caesarean birth (NG192)

    This guideline covers when to offer and discuss caesarean birth, procedural aspects of the operation, and care after caesarean birth. It aims to improve the consistency and quality of care for women and pregnant people who are thinking about having a caesarean birth or have had a caesarean birth in the past and are now pregnant again.

  3. Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal) (TA945)

    NICE is unable to make a recommendation on treosulfan (Trecondi) with fludarabine before allogeneic stem cell transplant for babies, children and young people aged 1 month to 17 years with non-malignant diseases. This is because Medac Pharma did not provide an evidence submission. We will review this decision if the company decides to make a submission.

    Sections for TA945

  4. NICE International

    An advisory service from the UK’s National Institute for Health and Care Excellence to help other countries improve their nation’s health and wellbeing

  5. CKS end user licence agreement

    CKS end user licence agreement

  6. Diagnostics advisory committee members

    Find out more about the diagnostics advisory committee members by reading their biographies. Dr Brian Shine (chair) Biography Brian is a

  7. Policies and procedures

    Our policies and procedures on topics including declarations of interest, gifts and hospitality, complaints, and more.

  8. COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188)

    This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations on care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It also includes advice on organising services for long COVID.

  9. Devices for remote monitoring of Parkinson's disease (DG51)

    Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT-ON (Sense4care) for remote monitoring of Parkinson’s disease

  10. Trade union facility time report

    The time and proportion of pay used by trade union representatives to carry out their union role

  11. Skin cancer (QS130)

    This quality standard covers preventing, assessing, diagnosing and managing skin cancer (melanoma and non-melanoma skin cancer). It describes high-quality care in priority areas for improvement.

  12. Artificial intelligence (AI)-derived software to help clinical decision making in stroke (DG57)

    Evidence-based recommendations on artificial intelligence-derived software to help clinical decision making in stroke

  13. Pharyngeal electrical stimulation for neurogenic dysphagia (IPG781)

    Evidence-based recommendations on pharyngeal electrical stimulation for neurogenic dysphagia. This involves passing a catheter through the nose and into the throat where it is used to deliver small amounts of electrical current. The current travels from the throat to the brain and stimulates the areas involved in swallowing.

  14. Neonatal infection (QS75)

    This quality standard covers preventing bacterial infection in newborn babies, treating pregnant women and pregnant people whose babies are at risk of infection, and treating newborn babies with suspected or confirmed bacterial infection. It includes when to give antibiotics to prevent and treat neonatal bacterial infection and describes high-quality care in priority areas for improvement. This includes early-onset (within 72 hours of birth) and late-onset (between 72 hours and 28 days following birth) neonatal infection.

  15. Temperature control to improve neurological outcomes after cardiac arrest (IPG782)

    Evidence-based recommendations on temperature control to improve neurological outcomes after cardiac arrest. This involves controlling a person’s body temperature while they are still unconscious after their heart has been restarted. Either their body is kept at a normal temperature of between 36.5°C and 37.5°C to prevent fever, or it is cooled to between 32.0°C and 36.0°C (therapeutic hypothermia).

  16. Clinical coding recommendations for NICE guidance

    We work with the clinical classifications service of NHS Digital to provide relevant clinical coding information for interventional procedure and...

  17. 300 people to benefit from new treatment for advanced breast cancer recommended by NICE following price deal

    Around 300 people are set to benefit following NICE’s recommendation of talazoparib for treating a type of locally advanced or metastatic breast cancer in final draft guidance published today (19 January 2024).

  18. Artificial intelligence (AI) and digital regulations service

    NICE's leading role in designing a new service to support the development and adoption of AI and data-driven technologies in health and care.

  19. Provider information

    Information about providers of medical and healthcare related content under the NICE Electronic and Print Content Framework Agreement

  20. Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer (TA946)

    Evidence-based recommendations on olaparib (Lynparza) with bevacizumab (Avastin) for high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer in adults.

  21. Developing NICE guidelines: the manual (PMG20)

    Developing NICE guidelines: the manual

  22. Early and locally advanced breast cancer: diagnosis and management (NG101)

    This guideline covers diagnosing and managing early and locally advanced breast cancer. It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.

  23. What we do

    Our fellows and scholars programmes closed at the end of March 2022. We are not accepting new applications. The alumni We'll continue

  24. What is the clinical and cost effectiveness of antibiotic prophylaxis to prevent spontaneous bacterial peritonitis (SBP) in people with cirrhosis and ascites?

    Recommendation ID NGO50/2 Question What is the clinical and cost effectiveness of antibiotic prophylaxis to prevent spontaneous bacterial

  25. Assessing the risk of cirrhosis:- Development of a risk tool to identify people at risk of cirrhosis.

    Recommendation ID NG50/4 Question Assessing the risk of cirrhosis:- Development of a risk tool to identify people at risk of cirrhosis

  26. More research is needed on using the following digital weight-management technologies:

    Recommendation ID HTE14 Question More research is needed on using the following digital weight-management technologies: Any explanatory

  27. For people after stroke with communication difficulties, what is the optimal tool for assessing fatigue?

    Recommendation ID NG236/3 Question For people after stroke with communication difficulties, what is the optimal tool for assessing fatigue

  28. What is the effectiveness of surgery in the prevention of MSCC for people with spinal metastases without pain or instability?

    Recommendation ID NG234/4 Question What is the effectiveness of surgery in the prevention of MSCC for people with spinal metastases without

  29. What are the effective forms of remobilisation for people with MSCC?

    Recommendation ID NG234/3 Question What are the effective forms of remobilisation for people with MSCC? Any explanatory notes(if

  30. Research should report:

    Recommendation ID IPG776 Question Research should report: Any explanatory notes(if applicable) short‑term and long‑term:

  31. How effective is stereotactic ablative radiotherapy compared with standard radiotherapy in the postoperative treatment of metastatic spinal cord compression (MSCC)?

    Recommendation ID NG234/1 Question How effective is stereotactic ablative radiotherapy compared with standard radiotherapy in the postoperative

  32. What is the effectiveness and cost effectiveness of intravenous compared with oral antibiotics for preventing postnatal infections after birth with forceps or ventouse?

    Recommendation ID NG235/5 Question What is the effectiveness and cost effectiveness of intravenous compared with oral antibiotics for preventing

  33. What is the most effective dosage at which oxytocin should be recommenced once stopped in labour because of an abnormal cardiotocography?

    Recommendation ID NG235/2 Question What is the most effective dosage at which oxytocin should be recommenced once stopped in labour because

  34. For a short explanation of why the committee made this recommendation for research, see the rationale section on position of the baby during cord clamping .

    Recommendation ID NG235/3 Question For a short explanation of why the committee made this recommendation for research, see the rationale

  35. What is the effectiveness and cost effectiveness of endoscopic variceal band ligation plus a non-selective beta-blocker compared with either of these interventions alone for preventing variceal bleeding in adults with cirrhosis and medium or large oesophageal varices?

    Recommendation ID NG50/1 Question What is the effectiveness and cost effectiveness of endoscopic variceal band ligation plus a non-selective

  36. What is the impact of pharmacological interventions for the management of postpartum haemorrhage on breastfeeding and women's and their birth companions' experience and satisfaction in the postnatal period?

    Recommendation ID NG235/4 Question What is the impact of pharmacological interventions for the management of postpartum haemorrhage on

  37. What is the effectiveness of hands on, hands poised or Finnish grip in the second stage of labour for reducing perineal trauma?

    Recommendation ID NG235/1 Question What is the effectiveness of hands on, hands poised or Finnish grip in the second stage of labour for

  38. What is the clinical and cost effectiveness of computer-based tools to treat problems with speech (dysarthria) and all domains of language (aphasia) for people with communication difficulties after stroke?

    Recommendation ID NG236/4 Question What is the clinical and cost effectiveness of computer-based tools to treat problems with speech (dysarthria)

  39. Further research should include details of patient selection and report longer term outcomes.

    Recommendation ID IPG777 Question Further research should include details of patient selection and report longer term outcomes. Any

  40. Further research should report:

    Recommendation ID IPG773 Question Further research should report: Any explanatory notes(if applicable) details of patient

  41. Further research should report details of patient selection, duration of the effect (including whether repeat procedures are needed), and long term outcomes.

    Recommendation ID IPG771 Question Further research should report details of patient selection, duration of the effect (including whether

  42. What are the effective forms of immobilisation for people with MSCC?

    Recommendation ID NG234/2 Question What are the effective forms of immobilisation for people with MSCC? Any explanatory notes(if

  43. Transjugular intrahepatic portosystemic shunt:- What is the quality of life in people who have had a transjugular intrahepatic portosystemic shunt (TIPS)?

    Recommendation ID NG50/7 Question Transjugular intrahepatic portosystemic shunt:- What is the quality of life in people who have had a

  44. More research is needed on the following artificial intelligence (AI)‑derived software to analyse chest X‑rays alongside clinician review for suspected lung cancer in adults referred from primary care:

    Recommendation ID HTE12/1 Question More research is needed on the following artificial intelligence (AI)‑derived software to analyse chest

  45. More research is needed on the following key outcomes:

    Recommendation ID HTE12/1 Question More research is needed on the following key outcomes: Any explanatory notes(if applicable)

  46. For people with different causes of shoulder pain after stroke, what is the clinical and cost effectiveness of interventions in reducing pain?

    Recommendation ID NG236/5 Question For people with different causes of shoulder pain after stroke, what is the clinical and cost effectiveness

  47. Further research should be in the form of randomised controlled trials or registries. It should report:

    Recommendation ID IPG778 Question Further research should be in the form of randomised controlled trials or registries. It should report: